Remove 2007 Remove Competition Remove Pharma
article thumbnail

Sweeping changes in leaked EU pharma law draft reignite profit vs access conflict

Pharmaceutical Technology

The EU is planning a sweeping revision of its pharma legislation in March, the largest change in 20 years. The revision process is reviving old conflicts in the pharma industry over fair and affordable access to medicines versus Europe’s status as a competitive home for pharma innovation.

Pharma 64
article thumbnail

Effective Pharma Ad Types & Stats

Pharma Marketing Network

With the increase in competition, it has become essential for pharmaceutical companies to find the most effective methods of advertisement to reach their target audience. ” New England Journal of Medicine, 2007. The post Effective Pharma Ad Types & Stats appeared first on Pharma Marketing Network. ” U.S.

Pharma 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Digitalising HPLC methods: the path to interoperability

European Pharmaceutical Review

Pre-competitive collaboration in this space benefits everyone because whether you are a biopharmaceutical company, vendor, publisher or equipment manufacturer, you are invested in ensuring the research ecosystem works seamlessly and drives new breakthroughs. What is your vision for the lab of the future?

article thumbnail

Achieving scale up success under economic uncertainty

European Pharmaceutical Review

For both small biotechs and large pharma, economic uncertainty is rising, intensifying decision-making risks associated with early drug discovery efforts, clinical trials, quality and manufacturing process execution, and navigating the approval process. In 2001 and 2007, through 2009, the economy was hit hard.

article thumbnail

U.S. market access landscape: A push for control is erasing the boundary between payers and providers in U.S. healthcare

Clarivate

After Walgreens upped its ownership stake in the primary-care company VillageMD from 30 to 63 percent and then announced plans to operate 1,000 clinics by 2027, the writing was on the wall: to stay competitive and manage costs in CVS’ newly integrated Aetna plan, CVS could benefit by making a larger bid for primary care of its own.

article thumbnail

Nine for 2023, part two: healthcare’s hard problem, the prognosis for diagnosis, and key new pharmacotherapy platforms

pharmaphorum

Across swathes of primary care, pharmacological innovation has stalled; the last new antihypertensive class was introduced in 2007 and new antibiotics have trickled in at a dangerously slow pace. To thrive, pharma must ask increasingly tough questions about the viability of candidates for clinical development.

FDA 98
article thumbnail

Enterprising Yourself At The Top Of The Spine Distributorship Game With Daniel Tighe

Evolve Your Success

I looked into capital equipment, pharma position, and one more position. I got the pharma position with GSK. This is 2007. You are so spoiled if you are trying to get into this now because there’s competition in this space for you to reach that next level. You need to look into that.” To do referral marketing?

Doctors 246